Loading...
OTCMCGSBF
Market cap2.69bUSD
, Last price  
0.00USD
Name

Corporativo Fragua SAB de CV

Chart & Performance

D1W1MN
OTCM:CGSBF chart
P/E
—
P/S
—
EPS
46.51
Div Yield, %
%
Shrs. gr., 5y
—
Rev. gr., 5y
15.44%
Revenues
109.37b
+11.70%
8,067,439,0009,832,198,00011,600,812,00014,575,199,00016,751,706,00019,146,767,00021,152,278,00023,237,265,00026,382,740,00028,955,200,00032,032,590,00035,790,002,00040,572,072,00046,673,744,00053,351,739,00061,884,200,00073,313,615,00084,794,429,00097,917,676,000109,374,181,000
Net income
4.50b
+41.59%
354,587,000463,632,000532,388,000672,074,000647,266,000609,333,000730,913,000848,560,000908,790,000963,193,000971,858,000973,567,0001,101,745,0001,343,092,0001,532,322,0001,709,995,0002,030,088,0002,621,797,0003,178,718,0004,500,600,000
CFO
6.37b
-23.96%
280,793,000492,361,000436,832,000309,229,000580,125,0001,273,625,0001,317,475,000928,658,0001,192,939,0001,086,348,0001,320,515,0002,079,544,0001,980,812,0001,723,572,0001,465,264,0002,856,981,0004,342,537,00013,468,502,0008,377,909,0006,370,933,000
Earnings
Feb 25, 2025

Profile

Corporativo Fragua, S.A.B. de C.V. operates pharmacy stores under the Superfarmacia name in Mexico. Its stores offer medicines, perfumery, photography, home, food, fruits and vegetables, bakery, sausage, and others. The company is also involved in the processing and sale of photographic equipment; and provides cargo services. Corporativo Fragua, S.A.B. de C.V. was founded in 1942 and is based in Guadalajara, Mexico.
URL
https://www.farmaciasguadalajara.com.mx/
IPO date
Oct 03, 1997
Employees
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
109,374,181
11.70%
97,917,676
15.48%
84,794,429
15.66%
Cost of revenue
84,364,698
77,019,505
67,214,770
Unusual Expense (Income)
NOPBT
25,009,483
20,898,171
17,579,659
NOPBT Margin
22.87%
21.34%
20.73%
Operating Taxes
2,640,018
2,433,559
2,047,675
Tax Rate
10.56%
11.64%
11.65%
NOPAT
22,369,465
18,464,612
15,531,984
Net income
4,500,600
41.59%
3,178,718
21.24%
2,621,797
29.15%
Dividends
(1,097,865)
(993,441)
(925,264)
Dividend yield
2.14%
2.77%
2.66%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,694,384
1,501,559
1,294,467
Long-term debt
3,848,534
3,744,782
3,314,724
Deferred revenue
(256,932)
(192,585)
Other long-term liabilities
745,509
540,215
452,109
Net debt
(2,771,900)
(2,544,620)
189,156
Cash flow
Cash from operating activities
6,370,933
8,377,909
13,468,502
CAPEX
(4,117,920)
(3,436,373)
(1,767,135)
Cash from investing activities
(3,859,301)
(3,249,041)
(1,740,417)
Cash from financing activities
(1,987,775)
(1,757,942)
(1,620,916)
FCF
27,174,069
16,772,488
14,391,064
Balance
Cash
8,314,818
7,790,961
4,420,035
Long term investments
Excess cash
2,846,109
2,895,077
180,314
Stockholders' equity
38,293,241
18,796,772
16,995,431
Invested Capital
23,896,127
18,894,696
19,292,559
ROIC
104.55%
96.71%
84.38%
ROCE
93.52%
94.79%
89.39%
EV
Common stock shares outstanding
102,600
102,596
102,599
Price
500.00
42.86%
350.00
3.11%
339.45
25.97%
Market cap
51,299,880
42.86%
35,908,675
3.11%
34,827,131
25.99%
EV
64,556,406
47,373,249
47,450,322
EBITDA
26,456,805
22,210,838
18,709,292
EV/EBITDA
2.44
2.13
2.54
Interest
481,113
1,176,624
Interest/NOPBT
1.92%
5.63%